Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 2022

View Archived Issues

Researchers discover genetic targets linking endometriosis, ovarian cancer subtypes

PKMYT1 inhibitor RP-6306 for the treatment of aberrant DNA damage repair-driven cancers

Chongqing Medical University compounds inhibit GST isozyme Mu, sensitize tumors to cisplatin in vivo

The role of DNA-PKcs and Fis1 in acute kidney injury pathogenesis

Hangzhou Bangshun Pharmaceutical discloses ROCK2 inhibitors

Targeting HIF-1alpha/CXCR4 axis as therapeutic strategy in ESCC

ASK1 inhibition for the treatment of neuroinflammation, stroke and ALS

Targeting ART1 improves tumor control in NSCLC

In vivo data show Evusheld retains neutralizing activity against Omicron SARS-CoV-2 BA.2 subvariant

RNAGene and PharmAbcine collaborate to develop next-generation mRNA-based antibody therapeutics

IRLAB to advance IRL-757 for apathy in neurodegenerative disorders

Chimeron to use NIAID preclinical services program for COVID-19 vaccine candidate

iTolerance raises financing to advance preclinical programs based on iTOL-100 platform technology

Philochem and Bracco Imaging collaborate on small molecule for imaging applications

AU-007 shows promising anticancer activity in murine models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...